Study identifies therapeutic target for Alzheimer’s disease, revealing strategy for slowing disease progression
Revolutionary leukemia treatment offers ‘a hopeful moment’ in fight against solid tumors
11 April 2022New approach for delivery of anti-HIV antibody therapy shows promise in phase I clinical trial
11 April 2022Study identifies therapeutic target for Alzheimer’s disease, revealing strategy for slowing disease progression
About 11% of the U.S. population 65 and older has been diagnosed with Alzheimer’s disease (AD), the most common form of dementia that results in memory loss and cognitive impairment, according to the Alzheimer’s Association.
